-
Mashup Score: 26HIV prevention drug hailed as a 'breakthrough' gets FDA approval - 23 day(s) ago
A drug called lenacapavir, administered in two injections a year, offers protection from HIV comparable to daily pills. One looming question: Will it be affordable for lower resource countries?
Source: www.npr.orgCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 26HIV prevention drug hailed as a 'breakthrough' gets FDA approval - 23 day(s) ago
A drug called lenacapavir, administered in two injections a year, offers protection from HIV comparable to daily pills. One looming question: Will it be affordable for lower resource countries?
Source: www.npr.orgCategories: General Medicine News, Infectious DiseaseTweet-
Yeztugo, a.k.a "yes to go" is new trade name for lenacapavir for HIV PrEP approved today by FDA! Price point $14k per dose, given twice yearly, seems priced to be at par with IM CAB and oral TAF/FTC for PrEP. Generic licences for LMIC access / lower cost. https://t.co/7R7WuiOdtI
-
-
Mashup Score: 3HIV RNA testing to monitor oral PrEP use does not add clinical value: a real-world cohort study—United States, 2019-2023 - 1 month(s) ago
Among a real-world cohort of oral PrEP users, HIV RNA testing increased after 2021 the CDC PrEP guideline update. However, RNA testing did not result in ea
Source: academic.oup.comCategories: General Medicine News, Infectious DiseaseTweet-
Clear example of when broad ranging recomme dations are made to address rare events...in this case delayed or atypical HIV seroconversions for those using oral or injectable PrEP Study shows time to stop doing viral load tests on everyone using oral PrEP https://t.co/NI5g46hBqD
-
-
Mashup Score: 2
Health officials say a measles outbreak in West Texas is growing because of low vaccine rates and undetected infections.
Source: www.cbsnews.comCategories: General Medicine News, Infectious DiseaseTweet-
Measles, a vaccine preventable disease, is spreading in TX and NM. I wonder why? https://t.co/v0cOplnvjw
-
-
Mashup Score: 4Iterum Therapeutics Receives U.S. FDA Approval of ORLYNVAH™ (Oral Sulopenem) for the Treatment of Uncomplicated Urinary Tract Infections - 9 month(s) ago
ORLYNVAH™ is the first oral penem approved for use in the U.S. and the second FDA-approved treatment for uUTIs in the past two decades –Company to…
Source: www.globenewswire.comCategories: General Medicine News, Infectious DiseaseTweet-
An oral carbapenem is FDA approved! Wowzer... https://t.co/xkEVUZnMpy
-
-
Mashup Score: 2An oral antiviral for Ebola disease - 10 month(s) ago
For those exposed to filovirus, such as Sudan virus and Ebola virus, a new study offers hope
Source: www.science.orgCategories: General Medicine News, Infectious DiseaseTweet-
@RwandaHealth @nsanzimanasabin @GileadSciences https://t.co/0UJ5cZUxf5
-
-
Mashup Score: 0Crack the Case #2: Crack the Case: Drug-Drug Interactions ***Post-Survey & Application for CME Credit*** - 10 month(s) ago
Take this survey powered by surveymonkey.com. Create your own surveys for free.
Source: www.surveymonkey.comCategories: General Medicine News, Infectious DiseaseTweet-
2/#MedTwitter COVID Outpatient Crack the Case ~ 🗓️Day1️⃣ In partnership w @BonumCE Supported by an edu grant from @Pfizer 🟢Next... 1:🎥Watch video 2:🟡Tune in tomorrow for Day 2️⃣answers 3:🔴Answer post-polls 3:🏆Claim🆓CME👉https://t.co/dCfrQb2Wxr 1⃣st: Tell us who you are
-
-
Mashup Score: 0Crack the Case #2: Crack the Case: Drug-Drug Interactions ***Post-Survey & Application for CME Credit*** - 10 month(s) ago
Take this survey powered by surveymonkey.com. Create your own surveys for free.
Source: www.surveymonkey.comCategories: General Medicine News, Infectious DiseaseTweet-
2/#MedTwitter COVID Outpatient Crack the Case ~ 🗓️Day1️⃣ In partnership w @BonumCE Supported by an edu grant from @Pfizer 🟢Next... 1:🎥Watch video 2:🟡Tune in tomorrow for Day 2️⃣answers 3:🔴Answer post-polls 3:🏆Claim🆓CME👉https://t.co/dCfrQb2Wxr 1⃣st: Tell us who you are
-
-
Mashup Score: 3
People with HIV (PWH) are living longer directly related to highly effective antiretroviral therapy (ART). However, concurrent with improved longevity is the growing prevalence of metabolic comorbi…
Source: www.tandfonline.comCategories: General Medicine News, Infectious DiseaseTweet-
Metabolic syndrome increasingly common among people with HIV. A nice resource for providers... we just published...discusses contemporary ART (including lenacapavir) and their interactions with hypertension, Diabetes, antiobesity, lipid lowering drugs https://t.co/GzO9TSNtaS
-
-
Mashup Score: 8
In a Phase 2/3 study, treatment with lenacapavir, a long-acting HIV-1 capsid inhibitor, plus an optimized background regimen, was well tolerated and result
Source: academic.oup.comCategories: General Medicine News, Infectious DiseaseTweet-
Our paper on 2 year efficacy and safety data for lenacapavir for people with multidrug resistant HIV, were viremic and had limited treatment options now published Bottom line...remarkable virologic suppression rates persist and well tolerated. https://t.co/nSuhu8izdW
-
Yeztugo, a.k.a "yes to go" is new trade name for lenacapavir for HIV PrEP approved today by FDA! Price point $14k per dose, given twice yearly, seems priced to be at par with IM CAB and oral TAF/FTC for PrEP. Generic licences for LMIC access / lower cost. https://t.co/7R7WuiOdtI